One of the Biggest Healthcare Frauds Ever Is Still Ongoing medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Natera Announces First Quarter 2021 Earnings Conference Call
News provided by
Share this article
AUSTIN, Texas, April 29, 2021 /PRNewswire/
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2021, after the market close on May 6, 2021. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.
Earnings Conference Call Information:
Date:
Live Dial-In:
About Natera
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women s health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, Calif
About Verici Dx plc www.vericidx.com Verici Dx is developing and commercialising tests to understand how a patient will and is responding to organ transplant, with an initial focus on kidney transplants. The body s own immune system poses a threat to a successful transplant or graft. Patients immune systems differ in how they respond to the presence of the transplanted organ, characterising this response is called immune phenotyping. Our products and solutions are underpinned by extensive scientific research into the recipient s immune phenotype and how that impacts on acute rejection, chronic injury and ultimately failure of the transplant. These immuno-profile signatures also inform clinicians as to the optimal strategy for immunosuppressive and other therapies for the most successful treatment to ensure graft acceptance with the least amount of side effects.
Image: Penn State
April 21, 2021
When an individual tests positive for COVID-19, CDC guidelines dictate those people must isolate for at least 10 days beginning with the first day of symptoms or the day of test if individual is asymptomatic. Individuals who have been placed in isolation
cannot test out of isolation.
The notion of testing out of isolation may be confused with testing out of quarantine. Under CDC quarantine guidelines, individuals who are placed in quarantine generally people who believe they may have come into contact with someone who has COVID-19 or have been identified as a close contact through contact tracing may be able to test out if they are not experiencing COVID-19 symptoms after five to seven days in quarantine. Penn State’s contact tracing team will work directly with students in quarantine to discuss test out options. Employees in quarantine can contact Occupational Medicine for consultation.
Could pooled testing really improve COVID-19 transmission management and decrease costs? news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.